Correlation Between FIXX Old and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both FIXX Old and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FIXX Old and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FIXX Old and Kymera Therapeutics, you can compare the effects of market volatilities on FIXX Old and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FIXX Old with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of FIXX Old and Kymera Therapeutics.
Diversification Opportunities for FIXX Old and Kymera Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between FIXX and Kymera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding FIXX Old and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and FIXX Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FIXX Old are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of FIXX Old i.e., FIXX Old and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between FIXX Old and Kymera Therapeutics
If you would invest (100.00) in FIXX Old on December 29, 2024 and sell it today you would earn a total of 100.00 from holding FIXX Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
FIXX Old vs. Kymera Therapeutics
Performance |
Timeline |
FIXX Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Kymera Therapeutics |
FIXX Old and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FIXX Old and Kymera Therapeutics
The main advantage of trading using opposite FIXX Old and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FIXX Old position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.FIXX Old vs. Passage Bio | FIXX Old vs. Stoke Therapeutics | FIXX Old vs. Adaptimmune Therapeutics Plc | FIXX Old vs. Black Diamond Therapeutics |
Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |